Cargando…
An ultrasensitive electrochemical sensing platform for the detection of cTnI based on aptamer recognition and signal amplification assisted by TdT
We have developed an ultrasensitive and highly specific electrochemical sensing platform for the detection of cardiac troponin I (cTnI), a recognized biomarker for the diagnosis of acute myocardial infarction (AMI) and related cardiovascular diseases (CVDs). This strategy is based on the assists of...
Autores principales: | Lang, Mingjian, Luo, Dan, Yang, Guangyi, Mei, Quanxi, Feng, Guangjun, Yang, Yang, Liu, Zhaohui, Chen, Qinhua, Wu, Lun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056971/ https://www.ncbi.nlm.nih.gov/pubmed/35517933 http://dx.doi.org/10.1039/d0ra05171c |
Ejemplares similares
-
TdT+ T-Lymphoblastic Proliferation in Castleman Disease
por: Woo, Chang Gok, et al.
Publicado: (2015) -
Biological Recognition-Based Electrochemical Aptasensor for Point-of-Care Detection of cTnI
por: Ma, Jianfeng, et al.
Publicado: (2023) -
The TDs/aptamer cTnI biosensors based on HCR and Au/Ti(3)C(2)-MXene amplification for screening serious patient in COVID-19 pandemic
por: Mi, Xiaona, et al.
Publicado: (2021) -
Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)
por: Tannenberg, Robert, et al.
Publicado: (2023) -
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
por: Ali, Muhammad, et al.
Publicado: (2021)